Skip to content
Stock screener

TMO Thermo Fisher Scientific Inc. stock chart & analysis

Conviction 52HealthcareScan · Fri, Nov 6, 2026

Thermo Fisher Scientific Inc. (TMO) closed at $694.76 (+2.63%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 55, RS Rating 90, -2.4% from its 52-week high, +19.9% year to date. Sector: Healthcare · Measuring & Controlling Devices, Nec.

TMO$694.76+2.63%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
Thermo Fisher Scientific Inc.Measuring & Controlling Devices, Necwww.thermofisher.com ↗
Price694.76
Change+2.63%
Gap-1.59%
Rel volume0.94×
Avg volume2.39M
Avg $ vol1.65B
SMA 20687.17
SMA 50660.81
SMA 200552.97
Price vs 50+5.16%
Price vs 200+25.66%
MA stackbullish
50/200 cross—
Supertrendup · 646.04
RSI (14)55
MACD hist-1.70
MACD crossbear · 4d
Stoch %K / %D66 / 62
ADX (14)23
+DI / −DI19 / 23
RSI divergence—
MACD divergence—
ATR %3.16%
ADR %3.15%
52w high712.17
52w low435.27
From 52w high-2.43%
Above 52w low+59.65%
New 52w highNo
SqueezeOn · 2d
Bollinger width7.67%
%B0.65
Donchian pos71.04%
Donchian high712.17
Donchian low652.50
AVWAP (52w high)692.25
vs AVWAP high+0.38%
AVWAP (52w low)582.22
vs AVWAP low+19.35%
OBV trendUp
Chaikin MF (20)0.15
Today vs 20d0.94×
Avg vol (14d)2.37M
Avg vol (20d)2.39M
Avg $ vol (20d)1.65B
Market cap257.47B
RS Rating90 / 99
RS 3m (vs SPY)+20.74%
RS 6m (vs SPY)+49.74%
RS line new highYes
Trend template8/8
Technical rank90.5
1 week-0.30%
1 month+6.58%
3 months+15.87%
6 months+49.44%
1 year+22.42%
YTD+19.92%
P/E38.41
P/B4.70
P/S5.78
P/FCF40.91
EPS17.74
Div yield0.25%
ROE12.24%
ROA5.87%
Debt/Eq0.79
Current1.81
EV/EBITDA—
Gross margin—
Net margin15.05%
Rev growth3.91%
EPS growth5.82%
Price target757.44
Target upside9.00%
Analyst ratingBuy
Institutional99.92%
Ent. value295.38B
Revenue12.14B
Net income1.72B
Gross profit—
Free cash flow6.29B
IndustryMeasuring & Controlling Devices, Nec
ExchangeNYSE
Shares out371.62M
Employees125K
ListedThu, Jun 1, 1972
Free float371.32M
Float %99.9%
Short interest—
Days to cover—
Short volume27.4%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$6.68 vs $6.40
Last surprise+4.4% beat
Setup gradeD
Conviction52 / 100
Pattern quality—
Tech rank90.5 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance709.94
Support641.68
Days since event—
Candle confirm—

Financials as of Sat, Sep 26, 2026 · quarterly.

TMO technical analysis

Trend

TMO is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 5.2% above the 50-day ($660.81) and 25.7% above the 200-day ($552.97). ADX(14) at 23 points to a moderate trend. It meets 8 of 8 trend-template criteria.

Momentum

RSI(14) is 55, in the bullish half of its range. MACD crossed below its signal line 4 sessions ago. Its RS Rating of 90 puts its weighted 12-month performance ahead of about 90% of the US market, and its RS line is at a new high.

Volume and volatility

Volume on the latest session ran 0.9× its 20-day average. It trades about $1.6B a day on average. ATR(14) is $21.94, 3.2% of price — its typical daily range. Bollinger Bands are in a squeeze (2 sessions) — volatility is compressed. On-balance volume is trending up. Chaikin Money Flow (0.15) shows accumulation.

Key levels

The chart pattern's support is $641.68 and its resistance $709.94. The 52-week range is $435.27 to $712.17; price is 2.4% below the high and 59.7% above the low. The VWAP anchored at the 52-week high is $692.25, below price.

Performance

TMO returned -0.3% (1 week), +6.6% (1 month), +15.9% (3 months), +49.4% (6 months), +22.4% (1 year), +19.9% (year to date).

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).

Measuring & Controlling Devices, Nec · Listed 1972 · 125,000 employees

Congress activity

Disclosed STOCK Act trades in TMO · 10 recent

All disclosures →
MemberSideAmount
Michael Rulli
Michael Rulli
house · R · OH · traded 2024-12-12
Sell$1K–$15K
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
Dan Newhouse
Dan Newhouse
house · R · WA · traded 2026-07-10
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-30
Sell$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2025-09-23
Sell$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2024-10-29
Buy$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2025-06-06
Buy$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2025-03-03
Sell$1K–$15K
Kelly Louise Morrison
Kelly Louise Morrison
house · D · MN · traded 2025-08-19
Sell$15K–$50K
Kelly Louise Morrison
Kelly Louise Morrison
house · D · MN · traded 2025-08-19
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in TMO · open-market 2 sells

InsiderSideShares
Britt Lisa P.
Sr. VP and Chief HR Officer · Common Stock · 2026-10-28
Sell2.83K
SPERLING SCOTT M
Director · Common Stock · 2026-10-28
Gift3.49K
Britt Lisa P.
Sr. VP and Chief HR Officer · Common Stock · 2026-08-28
Tax87.03
Britt Lisa P.
Sr. VP and Chief HR Officer · Common Stock · 2026-08-28
Tax116.04
Britt Lisa P.
Sr. VP and Chief HR Officer · Common Stock · 2026-08-28
Tax105.403
Britt Lisa P.
Sr. VP and Chief HR Officer · Common Stock · 2026-08-28
Tax85.096
CASPER MARC N
Chairman & CEO · Common Stock · 2026-08-28
Tax724.766
CASPER MARC N
Chairman & CEO · Common Stock · 2026-08-28
Tax531.851
CASPER MARC N
Chairman & CEO · Common Stock · 2026-08-24
Exercise275
CASPER MARC N
Chairman & CEO · Common Stock · 2026-08-24
Sell101

SEC filings

EDGAR filings in TMO · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.